Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches
Sensors · 25.12.2025 · 26 (1) · 145
DOI: 10.3390/s26010145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 25.12.2025. Verfasst von Salim El Kabbani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia. Hauptthemen laut MEDLINE: Biosensing Techniques, Dengue Virus, Dengue, Microfluidics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saudi Institute of Health [Saudi NIH], Saudi National Institute of Health [Saudi NIH].
Abstract (Originalsprache)
Dengue fever remains a major mosquito–borne disease worldwide, with over 400 million infections annually and a high risk of severe complications such as dengue hemorrhagic fever. The disease is prevalent in tropical and subtropical regions, where population density and limited vector control accelerate transmission, making early and reliable diagnosis essential for outbreak prevention and disease management. Conventional diagnostic methods, including virus isolation, reverse transcription polymerase chain reaction (RT–PCR), enzyme–linked immunosorbent assays (ELISA), and serological testing, are accurate but often constrained by high cost, labor–intensive procedures, centralized laboratory requirements, and delayed turnaround times. This review examines current dengue diagnostic technologies by outlining their working principles, performance characteristics, and practical limitations, with emphasis on key target analytes such as viral RNA; nonstructural protein 1 (NS1), including DENV–2 NS1; and host antibodies. Diagnostic approaches across commonly used biofluids, including whole blood, serum, plasma, and urine, are discussed. Recent advances in biosensing technologies are reviewed, including optical, electrochemical, microwave, microfluidic, and CRISPR–based platforms, along with the integration of artificial intelligence for data analysis and diagnostic enhancement. Overall, this review highlights the need for accurate, scalable, and field–deployable diagnostic solutions to support early dengue detection and reduce the global disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Engineering, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
ORCID-Profile: Gameel Saleh
Förderung
- Saudi Institute of Health [Saudi NIH]
- Saudi National Institute of Health [Saudi NIH]
Zitieren
APA
El Kabbani, S., & Saleh, G. (2025). Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches. Sensors, 26(1), 145. https://doi.org/10.3390/s26010145
Vancouver
El Kabbani S, Saleh G. Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches. Sensors. 2025;26(1):145. doi:10.3390/s26010145
BibTeX
@article{ElKabbani2025,
author = {El Kabbani, Salim and Saleh, Gameel},
title = {Next—Generation Diagnostic Technologies for Dengue Virus Detection: Microfluidics, Biosensing, CRISPR, and AI Approaches},
journal = {Sensors},
year = {2025},
volume = {26},
number = {1},
pages = {145},
doi = {10.3390/s26010145}
}
EUVIMED